Katsuaki Maehara: Key Insights from MRD Analysis of the ADAURA Trial

Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:

“Osimertinib – MRD analysis of the ADAURA

The following slides summarize the key points of this paper. (IMO)”